48,460
edits
Difference between revisions of "Prostate cancer"
Jump to navigation
Jump to search
→Seminal vesicle invasion
| Line 388: | Line 388: | ||
====Seminal vesicle invasion==== | ====Seminal vesicle invasion==== | ||
:Abbreviated ''SVI''. | |||
General: | General: | ||
*Typically upstages to | *Typically upstages to pT3b. | ||
*Associations:<ref name=pmid23194127>{{Cite journal | last1 = Sapre | first1 = N. | last2 = Pedersen | first2 = J. | last3 = Hong | first3 = MK. | last4 = Harewood | first4 = L. | last5 = Peters | first5 = J. | last6 = Costello | first6 = AJ. | last7 = Hovens | first7 = CM. | last8 = Corcoran | first8 = NM. | title = Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer. | journal = BJU Int | volume = 110 Suppl 4 | issue = | pages = 58-63 | month = Dec | year = 2012 | doi = 10.1111/j.1464-410X.2012.11477.x | PMID = 23194127 }}</ref> | |||
**Most SVI is by direct extension ~90%. | |||
**Approximately 20% of patients with pT3x have SVI. | |||
**Usually associated with a large tumour volume (22% versus 12%). | |||
Microscopic: | Microscopic: | ||